Annual Drug Patent Expirations for BYLVAY Bylvay is a drug marketed by Albireo and is included in one NDA. There are seven patents protecting this drug. This drug has one…
The post New patent for Albireo drug BYLVAY appeared first on DrugPatentWatch – …
Annual Drug Patent Expirations for AIRDUO+RESPICLICK Airduo Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are sixteen…
The post New patent for Teva Pharm drug AIRDUO RESPICLICK appear…
New patent for Teva Pharm drug AIRDUO RESPICLICK Read Post »
Annual Drug Patent Expirations for AIRDUO+DIGIHALER Airduo Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from four suppliers. There are twenty-three…
The post New patent for Teva Pharm drug AIRDUO DIGIHALER appe…
This chart shows the drugs with the most patents in Yugoslavia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.…
The post Which pharmaceutical drugs have the most drug patents in Yugo…
Which pharmaceutical drugs have the most drug patents in Yugoslavia? Read Post »
FOLOTYN (pralatrexate) Acrotech Patent: 6,028,071 Expiration: Jul 16, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug P…
Drug Patent Expirations for the Week of July 10, 2022 Read Post »
This chart shows the pharmaceutical companies with the most patents in Taiwan. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…
Which pharmaceutical companies have the most drug patents in Taiwan? Read Post »
Annual Drug Patent Expirations for BYFAVO Byfavo is a drug marketed by Acacia and is included in one NDA. There are ten patents protecting this drug. This drug has forty-four…
The post New patent for Acacia drug BYFAVO appeared first on DrugPatentWatch…
Annual Drug Patent Expirations for ENVARSUS+XR Envarsus Xr is a drug marketed by Veloxis Pharms Inc and is included in one NDA. It is available from one supplier. There are…
The post New patent for Veloxis Pharms drug ENVARSUS XR appeared first on Drug…
Annual Drug Patent Expirations for MAYZENT Mayzent is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are two patents protecting…
The post New patent for Novartis drug MAYZENT appeared first on DrugPaten…
Annual Drug Patent Expirations for BARHEMSYS Barhemsys is a drug marketed by Acacia and is included in one NDA. There are four patents protecting this drug. This drug has thirty-eight…
The post New patent for Acacia drug BARHEMSYS appeared first on Dru…
Get new actionable insights and updates from BiotechBlog
